Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PECAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CRYGS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMURF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105377443 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCFL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF346 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRMS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00327 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on